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Despite an increasing number of adults being affected by food allergy, there is currently limited 
research regarding the psychological impact of living with this condition in this age group and 
the effect of undergoing food challenge testing - the gold standard for diagnosis- on health-
related quality of life (HRQoL). 
Objectives 
To assess whether ruling out a food allergy using an open food challenge could improve HRQoL 
and emotional well-being. To evaluate whether HRQoL gains are higher among people testing 
negative for food allergy and whether people higher on health anxiety would be less reassured 
by a negative food challenge.    
Methods 
A cross-sectional study (n=276) and a prospective study (n=53) were  performed. Adults with 
a positive (n=34), or negative food challenge (n=34), or with an allergy confirmed via other 
means (No challenge, n=208), completed the Food Allergy Quality of Life Questionnaire-
Adult Form, General Health Questionnaire-12, State-Trait Anxiety Inventory short form, 
Positive and Negative Affect Schedule, shortened version of the Health Anxiety Questionnaire 
in addition to clinical and demographic variables. A prospective study examined these 
measures before and three months after a food challenge (negative, n=45; positive, n=8).   
Results 
Adults with a negative food challenge outcome had better HRQoL than those with a food 
allergy confirmed via other means (No challenge), with no  differences between the two allergy 
positive groups (food challenge vs. no challenge). No group differences in emotional distress, 
health anxiety or mood were found. The prospective study showed HRQoL significantly 
improved following a food challenge (F(1,39) = 16.868; p<0.001; Intention-to-treat F(1,52) = 
15.346; p<0.001). High health anxiety was not associated with lower reassurance following a 
negative test. 
Conclusions 
People who have a food allergy excluded following a food challenge have better HRQoL. There 
was a significant improvement in HRQoL following an open food challenge which supports 
the need to increase provision of food challenge testing in this age group.  
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Food allergies are an abnormal response of the body to otherwise harmless food proteins 
involving the immune system (1). The prevalence of food allergy has increased in recent 
decades and is now recognised as a substantial public health burden in developed countries 
with up to 10% affected (2, 3). Symptoms vary and can involve the skin, oropharyngeal tract, 
gastrointestinal tract, respiratory and cardiovascular systems, with the most severe and 
sometimes fatal manifestation being anaphylactic shock. Food allergy has an unpredictable 
nature and individuals with only mild reactions may have a severe and life-threatening reaction 
on re-exposure.  
 
Although research into possible treatments for food allergy including immunotherapy is being 
carried out, there is currently no cure.  Food allergic individuals must carefully avoid the causal 
foods on a daily basis and carry emergency treatment such as adrenaline in case they have a 
reaction. Thus, living with food allergies constitutes a unique stressor that is both chronic and 
acute, i.e. facing a daily threat of accidental allergen ingestion compounded by acute stress 
during allergic reactions (4).   
 
Diagnosis of food allergy involves taking a detailed clinical history to guide the requirement 
for skin prick and/or serum specific immunoglobulin E (sIgE) testing. When the clinical history 
and tests alone cannot provide a definitive diagnosis, or when the possibility of having 
outgrown an allergy exists, an oral food challenge is essential (5). A food challenge involves 
the graded administration of the potential culprit food in order to identify if an individual is 
allergic or tolerant, thereby confirming or excluding a diagnosis of food allergy.  
 
There is evidence that food allergy can lead to increased anxiety about food safety, social 
isolation and exclusion, and emotional pressure related to constant vigilance; impacting well-
being, mental health and quality of life (6-8). While some quantitative studies have examined 
the effect of food challenge tests on HRQoL (9-14), the majority have been on 
children/adolescents or their carers. To our knowledge, only one study has included adults and 
 
was done in the context of a double-blind, placebo-controlled food challenge (DBPCFC) (14). 
It found that HRQoL scores improved significantly after a DBPCFC when all outcomes of the 
test were combined compared to a control group with greater improvements after a negative 
outcome when a food allergy was ruled out than a positive outcome (food allergy confirmed). 
However, there is a need to assess whether this is the case for open food challenges which are 
the type of food challenges more commonly performed in clinical practice rather than 
DBPCFC. 
 
Another aspect that has received little attention in the context of food allergies is the role of 
health anxiety. People who are anxious about their health are more likely to misinterpret health 
information as personally threatening (15, 16); show adverse emotional reactions to ambiguous 
diagnostic test results, and are less reassured following the medical investigation of symptoms, 
even when there is no evidence of disease (e.g. 17, 18). Based on these findings, people with 
high health anxiety may be less reassured by a negative allergy test than people low on health 
anxiety. 
 
The present study was designed to assess the psychological impact of food allergy and open 
food challenges on HRQoL, emotional distress, health anxiety and negative mood in an adult 
population. Based on previous research we predicted that: 1) there would be better HRQoL and 
lower emotional distress, health anxiety and negative mood in people who test negative 
following a food challenge test. 2) HRQoL would improve among all people undergoing a food 
challenge test, but to a greater extent among people testing negative. 3) People higher on health 
anxiety would be less likely to be reassured by a negative food challenge.    
 
MATERIALS & METHODS 
Design 
This research consisted of two studies: 1) a cross-sectional study that compared HRQoL and 
psychological measures among adults with clinician confirmed food allergy diagnosis (based 
on clinical history, skin prick and/or serum sIgE testing) vs. adults who had undergone a food 
challenge test and 2) a prospective study that examined changes among people undergoing a 
food challenge test.  
A negative challenge was defined as tolerating the food without any evidence of allergic 
symptoms, thus allergy to the food tested was excluded while a positive outcome required the 





The North East-Sunderland National Research Ethics Service (NRES) Committee approved 
this research project in September 2013 (REC reference: 13/NE/0271). Following this, 
Research and Development approval was sought from the Royal Brompton and Harefield NHS 
Foundation Trust and was granted (2013AT007B). The research was conducted in accordance 
with the ethical standards established in the Declaration of Helsinki and informed consent was 
obtained from all participants before enrolment in the studies. 
 
Recruitment and participants 
Study 1 
Individuals that had previously attended the Allergy Department at Royal Brompton & 
Harefield NHS Foundation Trust, London and were diagnosed with food allergy based on 
clinical history, skin prick and/or sIgE tests (Group 1-FA-No challenge ) or who had previously 
undergone a clinically indicated food challenge (Group 2-Food Challenge) were identified 
from the medical records. The inclusion criteria for participating in this study were aged 18 or 
older, clinician confirmed IgE mediated food allergy or previous food challenge. Individuals 
could not participate if they were considered adults with incapacity.  
Study 2 
All individuals who were waiting to have a food challenge test between October 2013 to March 




Participants were asked to record their age, gender, ethnicity and educational qualifications.   
Food allergy characteristics 
Specifically designed questions were used to assess the foods that previously caused allergic 
symptoms, age when first experienced a reaction, treatment received, investigations for food 
allergy and adrenaline auto-injector possession. Participants who had undergone a food 
challenge test were asked about the number and type of food/s they had tested, time between 
the initial reaction and the food challenge test to the suspect food and outcome of the challenge. 
Health-related quality of life   
 
The FAQLQ-Adult Form was used in this study as this is the only disease-specific HRQoL 
questionnaire for food allergic adults (19), using a 5-point Likert scale with response options: 
0-not at all, 1-slightly, 2-moderately, 3-very and 4-extremely.  It has four subscales which can 
be combined to generate a total HRQoL score: Allergen Avoidance and Dietary Restrictions 
(AADR), example item ‘How troublesome do you find it that you have to be alert to what you 
are eating?’; Emotional Impact (EI), example item ‘How frightened are you of accidentally 
eating the wrong food?’;  Risk of Accidental Exposure (RAE), example item ‘How 
troublesome is it that labels are incomplete?’; Food Allery related Health (FAH), example item 
‘How worried are you that it is unclear to which foods you are allergic?’.  In Study 1, 
participants who had undergone a food allergy challenge test were asked to complete this in 
relation to their perceived quality of life now and prior to completing the challenge test. In 
Study 2 participants completed the questionnaire before the food challenge and three months 
after. 
Emotional distress 
Emotional distress was measured using the 12-item version of the General Health 
Questionnaire (GHQ-12) (20).  Responses were scored 0-3 and were summed to produce a 
scale from 0 to 36, with higher scores indicating greater distress. 
State anxiety 
State anxiety was assessed with the validated 6-item version of the Spielberger State Trait 
Anxiety Inventory (STAI) with response options on a 6 point scale (21). Responses were 
totalled giving a score of between 6 and 24, with higher scores indicating higher anxiety. 
Positive and Negative Affect was measured using the Positive and Negative Affect Schedule 
(PANAS) (22). Participants were asked how they feel ‘right now’. Participants were asked to 
rate the extent to which they experienced each of the emotions on a 5-point Likert scale ranging 
from “very slightly or not at all” to “extremely”. Both subscales range from 10 (low) to 50 
(high).  
Health anxiety  
A shortened version of the Health Anxiety Questionnaire (HAQ) (23, 17) was used in this study 
in order to assess the presence of health anxiety in our study population.  Participants responded 
using a 4-point Likert scale ‘not at all or rarely’, ‘sometimes’, ‘often’, ‘most of the time’, with 




Participants were asked whether they suffered from any other allergic conditions or any other 
medical conditions. 
Reassurance following a negative test was assessed with the following items: ‘If your test to 
any food was NEGATIVE (i.e. no symptoms) how reassured are you that you are not allergic 
to that food?’. Response options were: ‘Not at all’, ‘Slightly’, ‘Moderately’, ‘Very’ and 
‘Extremely’.  
Food re-introduction. Participants were also asked if they had re-introduced the food back into 
their diet if their food challenge test was negative (response options: ‘Yes, small amounts’, 
‘Yes, normal amounts’, ‘No, still avoiding’ or ‘No, haven’t re-introduced but not avoiding’). 
If they had not re-introduced it, what were the reasons (response options: ‘Fear of reaction’, 
‘Not convinced of negative test’, ‘Reaction on eating food after challenge’, ‘Not confident to 
try alone’, ‘Other’). 
If your challenge was negative, does this mean that you no longer need to carry any emergency 
medication? ‘Yes’ ‘No, I have other allergies’ 
 
Procedure 
All potential participants were provided with an information sheet including details about the 
study and a copy of the questionnaire. They were informed that participation was voluntary 
and that they had the right to withdraw at any time during the study. Furthermore, declining to 
take part in the study would have no impact on their care. They were also provided with the 
researchers contact details in case they had any questions about the research. If they wished to 
take part, they had to give written informed consent and complete the questionnaire provided 
with the information sheet and return in the enclosed stamped self-addressed envelope. 
  
Data analyses 
Statistical analyses were performed using SPSS software (IBM SPSS Statistics for Windows, 
Version 23.0, Armonk, NY: IBM Corp). Differences between groups were assessed using 
either General linear model (GLM) for continuous data or chi-square/ Fisher’s exact test for 
categorical data. Linear regression was used to assess differences between the groups on 
measures of HRQoL, emotional distress, health anxiety and mood. GLM was used to assess 
change in HRQoL between the two food challenge groups. The percentage of missing data was 
less than 5%. 
The sample size was calculated to detect a medium effect size (Cohen’s f2=0.15/ Cohen’s 
f=0.25) at 80% power and 5% significance level. For the linear regression, assuming ten 
 
predictors, the sample size was 118. For GLM to detect changes in pre- and post-challenge 
HRQoL scores for 2 groups (food challenge positive or negative) across two time points (before 
and three months after the test), the total sample size was 34 (G*Power, version 3.1.7) (24).  
RESULTS 
Study 1 
In total 276 individuals participated. Group 1 (FA-No challenge) consisted of adults with 
clinician confirmed food allergy but who had not undergone a food challenge test. The response 
rate for Group 1 was 83.2% with 208 adults (69.7% female- n=145) consenting to participate 
out of 250 eligible individuals. Group 2 (Food Challenge) included 68 adults who had 
previously undergone a food challenge test. All challenge tests were clinically indicated either 
for diagnostic purposes i.e. inconclusive skin prick/sIgE tests or to assess if individuals had 
outgrown an allergy i.e. suspected to no longer be allergic. The response rate for this group 
was 59.1% (68 out of eligible 115 individuals participated). Fifty percent of the 68  participants 
(n=34) had a negative challenge outcome i.e. allergy to tested food excluded (FC-Negative) 
and 50% (n=34) had a positive challenge test to a food (FC-Positive) i.e. allergy confirmed. 
 
In the total study sample (n=267), the majority were female (69.2% n=191), had educational 
qualifications (97.8%, n=261), and identified their ethnicity as White (73.6%, n=203). There 
were significant differences between the groups in age (F(2,273) =4.138; p=0.017); post-hoc 
comparisons showed the FC-Positive group were significantly older than Group 1 (p=0.024), 
but there was no difference in age between the FC-Positive and FC-Negative subgroups 
(p=1.000). There were no significant differences between the groups in terms of gender, ethnic 
group, or educational level (Table I). 
 
As is common in individuals with food allergies, many of the participants suffered with other 
allergic conditions. These included: asthma 59.1% (n=163) and allergic rhinitis 68.8% (n=190), 
although prevalence of other comorbidities such as heart disease was low. The FC-Positive 
group were more likely to have asthma than Group 1 (OR: 3.559, 95% CIs: 1.414 to 8.962, 
p<0.007), and the FC-Negative group (OR: 4.667, 95% CIs 1.540 to 14.143, p=0.006) with no 
difference between the FC-Negative group and Group 1 (OR: 1.311, 95% CIs: 0.634 to 2.710, 
p=0.465). There were no differences between the groups on other allergies or comorbidities. 
 
Food allergy profile, diagnosis and treatment 
 
Food allergy profiles across the groups are shown in detail in Table II. Forty-nine percent 
(n=112) reported that they had previously experienced symptoms consistent with anaphylaxis.  
There were no significant differences between the groups in terms of age of allergy onset, food 
type, anaphylaxis and treatment received. There was a significant difference in gastrointestinal 
(GI) symptoms between groups, with the FC-Negative less likely to report GI symptoms than 
Group 1 (p=0.017), but no differences between the other comparisons (FC-Negative vs. FC-
Positive; FC-Positive vs Group 1 ). There were no significant differences between the groups 
on the other symptoms. 
Among participants who underwent a food challenge, the mean length of time between first 
experiencing symptoms to the suspect food and undergoing a food challenge to that food was 
12.47 years, ranging from one month to 50 years.  
 
Adrenaline auto-injector possession 
65.2% (n=180) of all participants reported that they were advised to and were carrying 
adrenaline auto-injector devices.  There was a significant reduction in the proportion of people 
who reported carrying an adrenaline autoinjector who tested negative in the food challenge, 
(85.3%, n=29 pre-challenge vs. 61.8%, n=21 post-challenge; p=0.021). In the FC-Positive 
group there was no significant change (52.9 %, n=18 pre-challenge vs. 67.6%, n=23 post-
challenge; p=0.227).   
 
Health-related quality of life   
The FC-Negative group reported better HRQoL than Group 1, even after adjusting for age, 
presence of asthma and GI symptoms (factors that had differed across the three allergy groups). 
There was no difference in total HRQoL scores between the two groups with confirmed food 
allergy (FC-Positive vs Group 1) in both unadjusted and adjusted analyses (Table III). Presence 
of both asthma and GI symptoms were predictive of poorer HRQoL (p=0.006 and p<0.001 
respectively). The same pattern of significant results was seen in the HRQoL sub-scales AADR 
and FAH. No differences were observed between the FC-Positive or FC-Negative groups in 
comparison with Group 1 once the Bonferroni correction had been applied.  
 
Emotional distress and mood 
There were no differences between the three groups on emotional distress, state anxiety, or 
positive and negative affect.  The FC-Positive group reported lower levels of health anxiety 
 
than Group 1 in both unadjusted and adjusted analyses, although this was no longer significant 
following a Bonferroni correction (Table III).  
 
Change in HRQoL in food challenge group 
The GLM analysis showed a significant effect of time, with improvements in HRQoL (F (1,66) 
= 44.40, p<0.001). There was a non-significant trend between outcome of challenge and change 
in HRQoL, F(1,66) = 3.077, p=0.084, with a higher improvement in HRQoL scores in the 
challenge negative than the challenge positive group (0.762 vs 0.445 respectively).  
There were differences between the FC-Negative vs. FC-Positive in presence of asthma. When 
this was entered into the model, improvement in HRQoL over time remained significant 
(p<0.001) and the interaction became non-significant (p=0.214). 
 
Reassurance in results 
The mean levels of reassurance following a negative outcome were 3.882 (SD=1.274), with  
47.1% (n=16) responding ‘extremely’, 17.6% (n=6) ‘very’, 14.7% (n=5) ‘moderately’, 17.6% 
(n=6) slightly and 2.9% ‘not at all’ reassured. The correlation between health anxiety and 
reassurance for people testing negative was -0.076, p=0.670. 
 
Food re-introduction 
Participants with a negative challenge outcome responded that 76.5% had re-introduced the 
food tested back into their diet in normal amounts or small amounts. 2.9% had not re-introduced 
but were not specifically avoiding while 20.6% were still avoiding. The reasons given by those 
still avoiding were: fear of reaction (n=2), not confident to try alone (n=4) and reaction on 
eating food after challenge (n=1). 
 
Study 2 
Fifty-three out of 56 eligible individuals, agreed to take part (response rate 94.6%), completing 
questionnaires before the food challenge test (while on the waiting list) and immediately after 
test completion. 45 tested negative, and only 8 tested positive. Forty participants (75.5% 
response rate) completed a questionnaire three months after the challenge. Thirteen participants 
did not complete the final questionnaire despite being sent a reminder.  
The mean age of the 53 participants was 33.5 years (SD=12.5) with a range of 18 to 62 years. 
71.7% were female, 84.9% (n=45) had  educational qualifications and the majority identified 
their ethnicity as White (69.8%, n=37).  Many of the participants suffered with other allergic 
 
conditions in particular, asthma 62.3% (n=33), allergic rhinitis 60.4% (n=32) and atopic 
dermatitis 49.1% (n=26).  
The sample included participants with a range of food allergies and symptoms. The mean 
number of foods that participants reported as having previously experienced symptoms to was 
3.09 (SD=2.41, range 1 to 11 foods). 47.2% had experienced symptoms to peanut, 43.4% to 
tree nuts, fruits 37.7%, shellfish 34%, fish 24.5% as well as a variety of other foods. The 
symptoms experienced included oropharyngeal 64.2%, skin 71.7%, upper airway 30.2%, 
respiratory (lower airway) 43.4%, gastrointestinal 50.9% and anaphylaxis 37.7%. The mean 
age when individuals first experienced allergic symptoms to any food was 20.5 years 
(SD=16.4, rang 6 months to 56 years).  
The most common foods that were tested with food challenge were  tree nuts (34%, n=18), 
shellfish (24.5%, n=13), peanut (20.8%, n=11), and fish (17%, n= 9). The average time between 
first experiencing symptoms to a food and undergoing a challenge test to the suspect food was 
8.58 years (SD= 9.18) (range 3 months to 32 years; median 3 years). 
 
Health-related quality of life   
Change in HRQoL over time was computed for responders to the follow-up questionnaire, and 
using an intention-to-treat analysis, where baseline scores of non-responders were used as 
follow-up scores, thereby assuming no change in HRQoL (Table IV).  
In the 40 participants who completed the questionnaires at all time points, there was a 
significant change from before and after the challenge test in mean total score F(1,39) = 16.868, 
p <0.001. Intention to treat analysis was also significant (F(1,52) = 15.346; p <0.001). 
Significant differences were observed across all four subscales of the HRQoL questionnaire, 
although applying a Bonferroni correction (adopting a revised p value of p=0.01) meant the 
change in RAE was no longer significant (Table V).  
The results showed significant improvement in HRQoL following a food challenge in those 
testing negative. The small sample size among people testing positive meant the study was 
underpowered to test for differences in HRQoL according to test outcome. 
 
Emotional distress and mood 
There were no significant changes in emotional distress, health anxiety, state anxiety or positive 
mood over time (Table VI).  There were significant differences over time in both the PANAS-
negative score and state anxiety, due to lower anxiety and negative mood after the test than at 




Adrenaline auto-injector possession 
Prior to the challenge, 60.4% (n=32) of participants in the whole sample (n=53) reported that 
they possessed adrenaline auto-injector devices. Following the challenge only 50.9% (n=27) 
still required these. In the group who tested negative (n=45), the change in proportion of people 
carrying adrenaline autoinjectors approached significance (60%, n=27 vs 49%, n=22,  
p=0.063). There was no difference in the challenge positive group but the sample size was very 
small.  
 
Reassurance in results 
The mean levels of reassurance following a negative outcome were 4.000 (SD=1.247), with  
46.4% (n=13) responding ‘extremely’, 25.0 % (n=7) ‘very’, 17.9% (n=5) ‘moderately’, 7.1% 
(n=2) slightly and 3.6 % (n=1) ‘not at all’ reassured. The correlation between health anxiety 
and reassurance for people testing negative was -0.047, p=0.812. 
 
Food re-introduction 
Three months after the challenge, 95% of participants had introduced the food tested into their 
diet (50% normal amounts, 45% small amounts). The reasons given by the 5% still avoiding 
the food were: fear of reaction, not confident to try alone, reaction on eating food after 
challenge and not convinced of the negative test. 
 
DISCUSSION 
We examined HRQoL, emotional distress, health anxiety and mood among adults undergoing 
a food challenge, using both cross-sectional and prospective study designs. Study 1 showed 
that adults who had tested negative (FC-Negative) reported better HRQoL than people living 
with a clinician diagnosed food allergy who had not undergone a food challenge (Group 1). 
There were no differences in HRQoL between the FC-Positive group and Group 1. These 
results remained significant controlling for age, and presence of asthma or GI symptoms, which 
varied between the groups. The groups did not differ in relation to emotional distress, health 
anxiety or positive and negative mood. However, the overall sample mean for GHQ-12 was 
above the scores of 11-12 which is considered to indicate a risk of being diagnosed with a 
 
mental illness (20) thus showing that some food allergic adults have high levels of 
psychological distress.  
 
Consistent with previous research (14) there were significant improvements in HRQoL over 
time. The retrospective study (Study 1) showed significant changes in total HRQoL scores, 
with improvements in two out of four of the subscales (Allergen Avoidance & Dietary 
Restrictions and Food allergy related Health), while the prospective study (Study 2) showed 
significant improvements in three, with positive changes also observed in Emotional Impact. 
This suggests people may have greater difficulty recalling the emotional impact of an allergy 
than other aspects. Following a negative challenge, fewer individuals reported a need to carry 
adrenaline auto-injector devices than those with a positive test.  However, it is not clear why 
the FC-Negative group did not report lower levels of Risk of Accidental Exposure when they 
have had allergies to particular food groups ruled out.  
 
Contrary to predictions we found no differences in HRQoL among people testing positive 
compared with those testing negative. In Study 1, the interaction between time and food 
challenge outcome approached significance, but once group differences in the prevalence of 
asthma were controlled for, the interaction become non-significant. Having asthma was a 
significant independent predictor of HRQoL which is consistent with previous findings (8).  
Food allergies often co-exist with asthma (25), and can also trigger or worsen asthma symptoms 
making this relationship more complex (26).  Study 2 had too few positive challenge outcomes 
to test for group difference in HRQoL. Previous research has shown people testing positive 
also report increases in quality of life, although to a lesser extent than people testing negative 
(14). The benefits of a positive test include greater certainty about which foods to avoid, 
allowing the affected individual to develop adaptive strategies to better manage their condition 
that may lead to improvements in HRQoL.  
 
A novel aspect of this study was that health anxiety was also measured that has not been studied 
previously in food allergic individuals. Health anxiety refers to apprehension and fear that 
changes in bodily sensations may be indicative of a serious illness (16). Individuals with high 
health anxiety often fail to be reassured by medical tests (e.g. 17). However, among the 
negative challenge participants, there was no significant association between reassurance and 
health anxiety, but this part of the study was underpowered. Following a negative challenge, 
individuals are advised that they can introduce the food that they were avoiding back into their 
 
diets. In Study 2, 95% of participants re-introduced the food. However, in Study 1 only 76.5% 
had done so. This is an area that requires further studying in order to understand the reasons 
why individuals may not be convinced or trust the result to eat the food again.   
 
Of concern is the average time participants reported between first experiencing symptoms to a 
food and undergoing a challenge test to the suspect food: 12.47 years in Study 1 and 8.58 years 
Study 2. This may also reflect the lack of education of the public regarding food allergies in 
adults as well as the limited adult allergy services in the UK and the provision of food challenge 
tests. There is now also evidence that delaying food challenge tests is associated with direct 
and indirect economic costs (27, 28). 
 
Strengths and limitations  
A strength of this study is that it explored an area and a population that has received little 
attention, exploring HRQoL in adults with clinician-diagnosed food allergy and who had 
undergone a clinically indicated open food challenge in the UK using a disease specific 
questionnaire. Furthermore, emotional psychological distress, mood and health anxiety were 
assessed which has also not been explored in this group. 
 
The large sample of food allergic adults allowed for inclusion of participants with different 
ages and types of food allergies. However, a larger prospective study is needed to adequately 
assess whether FC-Positive and FC-Negative groups differ in relation to HRQoL, and to assess 
the relationship between health anxiety and failure to be reassured following a negative test.  
 
In the prospective study, participants were followed at three months after the challenge test. 
Future studies can potentially assess HRQoL at longer periods of time after challenge to assess 
whether this benefit from undergoing a challenge test is maintained as was the case in the 
retrospective study. Strategies for achieving a good response rate will need to be considered as 
in this study we found the response rate for the follow up questionnaire was reduced. 
  
In addition, a multi-centre as opposed to a single centre study, may have strengthened the 
external validity of our findings and reduced any potential bias due to other aspects of care 





The findings from this research indicate that the issues of living with food allergy faced by 
adults have a negative impact on their HRQoL. Undergoing an open food challenge test was 
found to significantly improve HRQoL. By making these tests more widely available in clinical 
practice and clarifying whether an individual is allergic or not, any uncertainty can be dispelled, 
unnecessary food restrictions can be avoided and HRQoL can be improved.   
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Gender % female (n) 69.2 (191) 69.7 (145) 67.6 (23) 67.6 (23) p=0.950 
Ethnic group %, (n)      
 White 73.6 (203) 71.6 (149) 82.4 (28) 76.5 (26) p=0.388 
(white vs 
non-white) 
 Mixed/multiple    
 ethnic  
5.8 (16) 
 
7.2 (15) 0 (0) 2.9 (1) 
 Asian/Asian British 12.3 (34) 13.5 (28) 8.8 (3) 8.8 (3) 
 Black/African/    




4.8 (10) 5.9 (2) 5.9 (2) 
 Other 3.2 (9) 2.9 (6) 2.9 (1) 5.9 (2) 
Highest Qualification     p=0.862+  
Degree or 
equivalent 
70.0 (187) 69.5 (139) 66.7 (22) 76.5 (26) 
Below degree level 27.7 (74) 28.0 (56) 30.3 (10) 23.5 (8) 
No qualifications 2.2 (6) 2.5 (5) 3.0 (1) 0 (0) 
Co-morbidities 
Allergic 
     
Asthma 59.1 (163) 56.7 (118) 82.4(28) a 50(17) b p=0.010 
Rhinitis 68.8 (190) 69.7 (145) 61.8(21) 70.6(24) p=0.633 
Atopic dermatitis 48.9 (135) 49.5 (103) 50(17) 44.1(15) p=0.835 
Eosinophilic 
oesophagitis 
0.7 (2) 0.5(1) 2.9 (1) 0(0) p=0.433+ 
Other       
Heart disease 1.4 (4) 0.7 (3) 0 (0) 2.9 (1) p=0.680+ 
Diabetes 2.9 (8) 2.4 (5) 5.9 (2) 2.9 (1) p=0.467+ 
Epilepsy 1.8 (5)  1.9 (4) 0 (0) 2.9 (1) p=0.760+ 
Stroke 0.4 (1) 0.5 (1) 0 (0) 0 (0) p=1.000+ 
Arthritis 9.1 (25) 8.2 (17) 17.6 (6) 4.9 (2) p=0.212+ 
Mental/Emotional 
disorder 
8.7 (24)  8.7(18) 5.9 (2) 11.8 (4) p=0.673+ 
Other illness 18.5 (52) 20.7 (43) 8.8 (3) 17.6 (6) p=0.275+ 
 
Valid percent where people indicated they did not wish to answer. 
+  - Fisher’s exact 
a Significant difference between FC-Positive group and Group 1 (FA-No challenge group) 
b Significant difference between FC-Positive and FC-Negative groups 
 
Table II: Allergy profile characteristics of participants per group in Study 1 




No challenge  
(n=208) 










Age first experienced food 








Food involved % (n)     
Peanut  39.9 (83) 38.2 (13) 38.2 (13) p=0.971 
Tree nuts 41.8 (87) 41.2 (14) 35.3 (12) p=0.772 
Fish  15.9 (33) 14.7 (5) 20.6 (7) p=0.759 
Shellfish  25.5 (53) 32.4 (11) 32.4 (11) p=0.543 
Milk  13.5 (28) 14.7 (5) 14.7 (5) p=0.874 + 
Egg 16.3 (34) 14.7 (5) 17.6 (6) p=0.947 
Wheat 12.5 (26) 5.9 (2) 5.9 (2) p=0.434 + 
Soy 13.9 (29) 14.7 (5) 5.9 (2) p=0.491 + 
Sesame  8.7 (18) 14.7 (5) 11.8 (4) p=0.454 + 
Celery 8.2 (17) 14.7 (5) 0 (0) p=0.051 + 
Mustard 3.4 (7) 8.8 (3) 2.9 (1) p=0.313 + 
Lupin 3.8 (8) 2.9 (1) 5.9 (2) p=0.866 + 
Fruits/vegetables 51.4 (107) 50.0 (17) 35.3 (12) p=0.217 
Other  38.9 (81) 32.4 (11) 50.0 (17) p=0.313 
Number of foods involved 
in reactions, mean (sd) 
3.34 (2.35) 3.35 (2.70) 2.91 (1.87) p=0.610 
Symptoms     
Oropharyngeal 77.9 (162) 61.8 (21) 67.6 (23) p=0.082 
Skin 
(rash/urticaria/eczema) 
61.5 (128) 67.6 (23) 67.6 (23) p=0.663 
Angioedema 76.9 (160) 76.5 (26) 73.5 (25) p=0.911 
Upper respiratory 36.5 (76) 23.5 (8) 32.4 (11) p=0.322 
Lower Respiratory 56.3 (117) 73.5 (25) 67.6 (23) p=0.099 
Gastrointestinal 46.2 (96) 41.2 (14) 23.5 (8) c p=0.046  
Other 6.7 (14) 8.8 (3) 11.8 (4) p=0.467 + 
Anaphylaxis 38.9 (81) 41.2 (14) 50.0 (17) p=0.475 
Treatment received      
Antihistamines 84.6 (176) 94.1 (32) 94.1 (32) p=0.180 + 
Steroids 42.8 (89) 47.1 (16) 52.9 (18) p=0.518 
Adrenaline 32.7 (68) 50.0 (17) 47.1 (16) p=0.061 
No treatment 8.2 (17) 2.9 (1) 2.9 (1) p=0.508 + 
+ - Fisher’s exact 
c Significant difference between Group 1 (FA-No Challenge) and FC-Negative groups 
 
 
Table III: Quality of life, emotional distress, health anxiety and mood among participants with different allergy tests and test outcomes Study 1. 
Numbers are means (SDs). 











p value Adjusted 
differenced 
(95% CIs)  









Quality of life 
























































































































































































































a= no missing data; b= missing data <5%; c= missing data >5%.  
d adjusted for age, asthma and gastrointestinal symptoms. 
*Significant at p<0.006 (p adjusted for multiple comparisons)  
 
Table IV: HRQoL at baseline and three months post-challenge in Study 2. Means (standard deviation) 







Challenge outcome (N=40)   




 F (1,39) = 16.868; p<0.001 

















F (1,6) = 1.695; p=0.241 
Intention-to-treat (N=53)   















































 Baseline 3 months post-
challenge  
Significance 











F (1,39) = 11.790; p<0.001 




F (1,39) = 10.485; p=0.002 






F (1,39) = 5.741; p=0.021 






F (1,39) = 24.471; p<0.001 











F (1,52) = 11.045; p=0.002 




F (1,52) = 9.898; p=0.003 






F (1,52) = 5.576; p=0.022 






F (1,52) = 21.341; p<0.001 
 
 
Table VI: Psychological measures over time. Study 2. Means (SD)  
 Baseline Immediately after 
the challenge  
3 months post-challenge  Significance 
Completers only (N=40)     
Health anxiety  0.613  
(0.503) 
- 0.725  
(0.476) 
F(1,39) = 2.983; p=0.092 
GHQ-12 11.400  
(5.339)   
- 10.650  
(6.904) 









F (1.780,69.421) = 15.038, p < 0.001 






F(2,78) < 1; p=0.705 






F(2,78) = 9.642; p<0.001 
Intention to treat analysis 
(N=53) 
    






F(1,52) = 2.946; p=0.092 
























F(2,104) < 1; p=0.609 






F(2,104) = 14.773; p<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
